Gene · 7067
Papers1,888
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,888
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lithium Therapeutic Functions: An Update on Pharmacokinetics, Pathophysiological Mechanisms of Action, Toxicity, and Side Effects. | Mol Neurobiol | 2026 | 41627641 | PubTator, text mining | PubMed |
| The metabolic dysfunction-associated steatohepatitis (MASH) drug resmetirom exhibits broad nuclear receptor activity with minimal functional impact. | Sci Rep | 2026 | 41611794 | PubTator, text mining | PubMed |
| Pediatric Salmonella Poona gastroenteritis with bacteremia linked to exposure to a pet turtle: a case report. | J Rural Med | 2026 | 41568116 | PubTator, text mining | PubMed |
| Transcriptomic profiling and machine learning uncover gene signatures of psoriasis endotypes and disease severity. | Commun Med (Lond) | 2026 | 41565778 | PubTator, text mining | PubMed |
| Machine Learning Models for High-Throughput Screening of Obesogens Based on Pathway Network. | Environ Health (Wash) | 2026 | 41562031 | PubTator, text mining | PubMed |
Development of novel salicylic acid derivatives with dual anti-inflammatory and anti-arthritic potentials: synthesis, in vitro bio-evaluation, and in silico toxicity prediction with molecular modeling simulations. | RSC Adv | 2026 | 41550833 | PubTator, text mining | PubMed |
| Decabromodiphenyl ethane, a flame retardant, acts as a thyroid hormone receptor antagonist. | Toxicol Res | 2026 | 41503439 | PubTator, text mining | PubMed |
| The Clinical and Genetic Diversity of Thyroid Hormone Resistance: Four Clinical Vignettes. | Horm Res Paediatr | 2026 | 39476806 | PubTator, text mining | PubMed |
| Nuclear Receptor-Targeted Therapy for Metabolic Dysfunction-Associated Steatotic Liver Disease. | Int J Drug Discov Pharm | 2025 | 41938103 | PubTator, text mining | PubMed |
| CHRONO regulates the circadian clock via the REV-ERBα - BMAL1 loop. | NPJ Biol Timing Sleep | 2025 | 41776005 | PubTator, text mining | PubMed |
| Endocrine regulation of circadian rhythms. | NPJ Biol Timing Sleep | 2025 | 41775850 | PubTator, text mining | PubMed |
| Uncovering the genetic architecture of ME/CFS: a precision approach reveals impact of rare monogenic variation. | J Transl Med | 2025 | 41444612 | PubTator, text mining | PubMed |
| Comprehensive and In-Depth Molecular and Pathway Studies of the Hippocampus in Alzheimer's Disease. | Cell Mol Neurobiol | 2025 | 41317176 | PubTator, text mining | PubMed |
| Resmetirom, the first FDA-approved drug for MASH: From drug discovery and action mechanisms to clinical trials. | Arch Pharm Res | 2025 | 41166060 | PubTator, text mining | PubMed |
| In silico development of RNA aptamer candidates against thyroid receptor. | J Comput Aided Mol Des | 2025 | 41145852 | PubTator, text mining | PubMed |
| Repurposing levothyroxine for managing metabolic dysfunction-associated steatotic liver disease. | Endocrine | 2025 | 41129062 | PubTator, text mining | PubMed |
| Developing genome typing strategies for the emerging zoonotic pathogen Streptococcus parasuis. | J Clin Microbiol | 2025 | 41117601 | PubTator, text mining | PubMed |
| Precision Target Discovery for Migraine: An Integrated GWAS-eQTL-PheWAS Pipeline. | Molecules | 2025 | 41097341 | PubTator, text mining | PubMed |
Extraction and dual-phase optimization of anticancer doses of selective novel flavonoids from yangmei (Myrica rubra) in CRISPR-KO TRα cell lines of PTC: insights into Traditional Chinese Medicine for targeted therapeutic manufacturing. | 3 Biotech | 2025 | 41049528 | PubTator, text mining | PubMed |
| DeepEPI: CNN-transformer-based model for extracting TF interactions through predicting enhancer-promoter interactions. | Bioinform Adv | 2025 | 41031058 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7067/papers?page=2